コンテンツへスキップ
Merck
  • Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells.

Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells.

OncoTargets and therapy (2018-06-21)
Xueqing Li, Bing Pei, Hui Wang, Chenghui Tang, Wei Zhu, Feng Jin
要旨

Based on the functionality of AQP-5 characterized in various physiological processes, our study aimed to investigate the effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells. The expression levels of AQP-5 mRNA in different experimental groups were measured by reverse transcription PCR. The chemosensitivity of the cells to adriamycin (ADR) was detected by a CCK-8 kit. Cell invasion, migration, and apoptosis were assessed. Western blot was used to detect the expression levels of AQP-5, drug resistance-related protein, and apoptosis-related protein. The expression level of AQP-5 in MCF-7/ADR cells was significantly reduced by AQP-5 siRNA transfection. The invasion and migration were significantly reduced in MCF-7/ADR after AQP-5 siRNA interference. AQP-5 silencing significantly increased the chemosensitivity of MCF-7/ADR cells to ADR and activated caspase-dependent apoptosis in MCF-7/ADR cells. AQP-5 silencing also decreased the expression levels of drug resistance-related proteins (P-gp and GST-π). The inhibition of AQP-5 expression may reverse the drug resistance and enhance the chemosensitivity of breast cancer cells.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(Tyr[SO3H]27)コレシストキニンフラグメント 26-33 アミド, ≥97% (HPLC), powder
Sigma-Aldrich
MISSION® esiRNA, targeting human AQP5